Lupin 2024

CEO Levin exits Teva

NEW YORK — Jeremy Levin has resigned as chief executive officer at Teva Pharmaceutical Industries Ltd. and has been replaced on an interim basis by finance chief Eyal Desheh. The shake-up at the world’s largest manufacturer of generic drugs came despite the fact that Teva and Levin had previously denied an Israeli media report that

Crossmark names vice president

PLANO, Texas — Crossmark has named former GlaxoSmithKline PLC (GSK) executive Janet Carter Smith as vice president of business development. In her new role, Carter Smith will focus on working with new client opportunities across the company’s portfolio of services. "We are very excited about the customer connectivity, industry experience and problem-solving skills Janet brings

Walgreens offering free Part D plan reviews

DEERFIELD, Ill. — With this year’s Medicare Part D registration period overlapping with open enrollment for the new health insurance marketplaces, Walgreen Co. has recognized a growing need to help Medicare beneficiaries understand their drug coverage options. With Part D enrollment opening October 15, Walgreens pharmacists are offering free, personalized prescription drug plan comparison reports

Rexall, PharmaSmart in MTM joint venture

MISSISSAUGA, Ontario — Rexall Pharma Plus is partnering with Rochester, N.Y.-based PharmaSmart International Inc. on medication therapy management. The alliance integrates PharmaSmart interoperable biometric screening technology with Rexall’s dispensing system. The integration triggers timely patient interventions and counseling sessions, and increases MTM for hypertensive patients. Rexall pharmacists are presented alerts within the electronic patient record,

Gourlay to move from Alliance Boots to Walgreens

Gourlay to move from Alliance Boots to Walgreens

DEERFIELD, Ill. — Walgreen Co. and Alliance Boots GmbH have named Alex Gourlay, chief executive officer of the health and beauty division, Alliance Boots, as a Walgreens executive vice president and president of customer experience and daily living, effective October 1. In his new role Gourlay will report to Walgreens president and CEO Greg Wasson

Drug chains gear up for ACA educational push

NEW YORK — Walgreen Co. and CVS Caremark Corp. are conducting outreach campaigns to educate consumers about health insurance options under the Affordable Care Act. CVS Caremark’s effort will include in-store events, brochure displays and online information at cvs.com/insurance. Walgreens is engaged in a national initiative with the Blue Cross and Blue Shield Association (BCBSA).

Flum guides retail pharmacy at CVS

WOONSOCKET, R.I. — No one in 1997 would have predicted that Josh Flum would become one of the most important pharmacy executives in the country. That year he graduated from Yale Law School and started on a journey that took him from the U.S. Court of Appeals for the Third Circuit, where he served as

NEHI offers guidance on promoting Rx adherence

CAMBRIDGE, Mass. — NEHI has issued a report highlighting what it terms six “priorities for action” to improve patient medication adherence. The report underlines the importance of increasing awareness of medication therapy management (MTM). The NEHI report follows closely on the heels of efforts by pharmacy advocates, including the National Association of Chain Drug Stores

Pfizer separates operations

NEW YORK — In a move that industry insiders see as a possible prelude to spinning off its generics drug business, Pfizer Inc. said it plans to separate its commercial operations into two units mainly for patent-protected branded treatments and a third for generics. The drug manufacturer said the changes will go into effect in

Perrigo agrees to acquire Elan

ALLERGAN, Mich. — Perrigo Co. is acquiring Elan Corp., an Irish pharmaceutical firm, for $8.6 billion in a transaction that should give the manufacturer of over-the-counter drugs a low tax base for international ­expansion. Purchasing Dublin-based Elan enables Perrigo to redomicile itself in Ireland, where the corporate income tax rate is 12.5% and gives Perrigo

Walgreens, HHS develop MTM for HIV patients

Walgreens, HHS develop MTM for HIV patients

WASHINGTON — Walgreen Co. and the Department of Health and Human Services (HHS) have joined forces to develop a medication therapy management (MTM) program to help improve outcomes for HIV patients. The initiative, which will see Walgreens provide $1 million worth of in-kind services, is expected to help shed light on how the patient-pharmacist relationship

Walmart debuts PL diabetes care line

BENTONVILLE, Ark. — Walmart on Tuesday launched a private label diabetes care line that it said could save U.S. patients up to $60 million annually. The ReliOn products promise an affordable, quality option to help the country’s nearly 26 million individuals with diabetes. The ReliOn Prime meter is priced at $16.24, while ReliOn Prime blood

Supreme Court sides with generics supplier

WASHINGTON — The Supreme Court has ruled that Novo Nordisk’s description of the patent for Prandin, its diabetes drug, is too broad. This decision enables generic drug manufacturer Caraco Pharmaceuticals to sue the innovator company in an effort to force Novo Nordisk to narrow its patent description. The high court overturned an appeals court ruling

Walgreens names group VP managed market sales

DEERFIELD, Ill. — Walgreen Co. today named former Pfizer Inc. executive Robyn Peters as group vice president of managed market sales. She replaces chief client officer Joseph Terrion, who is leaving the company to pursue personal interests. Peters has spent the past 25 years in health care marketing, market access and reimbursement, and business development

PP_1170x120_10-25-21